Neuropathology Flashcards
Gross changes seen in Alzheimer’s disease
Generalised atrophy
Flattened sulci
Enlarged ventricles
Peptides which make up amyloid plaques in Alzheimer’s disease
Amyloid beta
Protein which amyloid beta is a fragment of
Amyloid-beta precursor protein
Conformation of amyloid plaques
Beta pleated sheets
Enzymes which cause amyloid-beta precursor protein to be cleaved into amyloid plaques in Alzheimer’s disease
Beta secretase
Gamma secretase
Enzyme which prevents the formation of amyloid plaques from amyloid-beta precursor protein
Alpha secretase
Two main subtypes of amyloid plaques
Neuritic plaques
Diffuse plaques
Form of amyloid which is found in neuritic plaques
Fibrils
Cell types found in neuritic plaques
Dystrophic neurites
Microglia and astrocytes at the periphery
Core of neuritic plaques
Dense amyloid core
Stain neurites are best visualised with
Silver stain
Stain of neuritic plaques under Congo red
Apple green birefringent
Component of diffuse plaques
Non-fibrillar extracellular amyloid beta
Main component of neurofibrillary tangles
Hyperphosphorylated tau protein
Purpose of tau protein
Microtubule assembly
Components required to make abnormally phosphorylated tau
Beta amyloid peptide
Cholinergic receptors
Conditions apart from Alzheimer’s disease where neurofibrillary tangles can be seen
Down syndrome
Dementia pugilistica (punch drunk syndrome)
Parkinson’s dementia
Normal aging
Appearance of neurofibrillary tangles on staining
Basophlic
Position of neurofibrillary tangles vs. beta amyloid plaques
Neurofibrillary tangles largely intraneuronal
Amyloid plaques extracellular
Earliest parts of the brain neurofibrillary tangles are seen - not usually associated with clinical symptoms
Entorhinal complex
CA1 field of the hippocampus
Parts of the brain affected by neurofibrillary tangles at the point clinical symptoms are first seen - as well as the entorhinal complex and CA1 region of the hippocampus
Other parts of the hippocampus
Medial temporal lobe
Then hypothalamus and thalamus
Condition caused by the accumulation of amyloid beta in blood vessel walls in the cerebral cortex
Cerebral amyloid angiopathy
Percentage of elderly population without Alzheimer’s disease who have cerebral amyloid angiopathy
30%
Percentage of elderly people with Alzheimer’s disease who have cerebral amyloid angiopathy
90%
Complication of cerebral amyloid angiopathy
Strokes - especially haemorrhagic
Eosinophilic bodies seen in the cytoplasm of neurons in patients with Alzheimer’s disease
Hirano bodies
Shape of Hirano bodies
Rod shaped
Protein involved in Hirano bodies
Actin
Area of the brain where Hirano bodies are often seen
Hippocampal pyramidal cells
Best neuropathological correlate for clinical decline in patients with Alzheimer’s
Number of synapses
Neuropathological marker used to measure the number of synapses in patients with dementia
Antibody to synaptophysin (protein found in presynaptic endings)
Alternative names for Binswanger’s disease
Subcortical vascular dementia
Subcortical arteriosclerotic encephalopathy
Cause of Binswanger’s disease
Multiple small infarctions to the deep layers of white matter in the brain
Clinical features of Binswanger’s disease
Memory issues (not as severe as with Alzheimer’s disease)
Psychomotor retardation
Unsteady, slow gait
Urinary urgency or incontinence
Areas of the brain where neuronal loss is seen the most in Alzheimer’s dementia
Subiculum of the hippocampus
Layers II and IV of the entorhinal cortex
Appearance of Lewy bodies
Spherical
Eosinophilic
Part of the cell Lewy bodies are found
Cytoplasm
Two main types of Lewy bodies
Classical
Cortical
Area of the brain Lewy bodies are found in Parkinson’s disease
Substantia nigra - pars compacta
Areas of the brain Lewy bodies are found in dementia with Lewy bodies
Substantia nigra
Temporal lobe
Cingulate gyrus
Frontal lobes
Differences in appearance between classical (found in the substantia nigra) and cortical Lewy bodies
Classical Lewy bodies are more conspicuous, more eosinophilic and have a halo
Markers which can be used to identify Lewy bodies
Antibody to ubiquitin
Antibody to alpha-synuclein
Protein accumulations found in Lewy bodies
Abnormal alpha-synuclein
Some ubiquitin
Abnormal neurons seen in dementia with Lewy bodies, Parkinson’s disease dementia and occasionally Alzheimer’s dementia
Lewy neurites
Area of the brain where Lewy neurites are most common
CA2/3 region of the hippocampus
Substantia nigra
Diseases associated with alpha-synuclein aggregation
Parkinson’s disease
Dementia with Lewy bodies
Multisystem atrophy
Diseases associated with tau deposits
Alzheimer’s dementia
Frontotemporal dementia
Progressive supranuclear palsy
Most common pathological type of frontal lobe dementia
Frontal lobe degeneration type
Three clinical types of frontotemporal dementia
Behavioural variant FTD
Semantic variant primary progressive aphasia
Non-fluent variant primary progressive aphasia
Features of behavioural variant FTD
Loss of inhibition
Loss of motivation
Repetitive or obsessive behaviours
Features of semantic variant primary progressive aphasia
Loss of vocabulary
Inability to remember what familiar objects are for
Features of non-fluent variant primary progressive aphasia
Different speech - changing grammar, words in the wrong order
Use of shorter sentences
Saying the opposite of what is meant
Retention of ability to know what words mean (in contrast to semantic variant primary progressive aphasia)
Proteins associated with frontotemporal lobar degeneration
Tau
Transactive response DNA binding protein (TDP 43)
Fused in sarcoma protein (FUS)
Macroscopic changes seen in frontotemporal lobar degeneration
Atrophy of frontal and temporal lobes
Focal atrophy with knife-blade appearance
Pathological type of frontotemporal lobar degeneration associated with Pick bodies
Tau type
Shape of Pick bodies
Sphrerical
Protein composing Pick bodies
Tau
Proteins seen aggregated in TDP frontotemporal lobar degeneration
Ubiquitin
TDP-43
Macroscopic changes seen in Huntington’s disease
Shrunken head of caudate
Dilatation of the anterior horns of the lateral ventricles
Three types of Creutzfeldt-Jakob disease
Sporadic
Familial
Variant
Most common type of Creutzfeldt-Jakob disease
Sporadic
Lobe generally spared in Alzheimer’s disease
Occipital
Brain area showing particular depigmentation in Alzheimer’s disease
Locus Coeruleus
Area of the brain which degenerates in Alzheimer’s disease leading to lower levels of acetylcholine
Nucleus of Meynert/nucleus basalis magnocellularis
Difference between Lewy bodies and Hirano bodies
Lewy bodies contain ubiquitin
General age of presentation of sporadic CJD
55-65
General age of presentation of variant CJD
25-30
Origin of variant CJD
Infected meat products
Origin on sporadic CJD
Genetic mutation
Duration of disease between onset and death for sporadic CJD
Few months
Duration of disease between onset and death for variant CJD
Year +
Earliest clinical features of sporadic CJD
Neurological signs - cerebellar ataxia, myoclonic jerks
Dementia
Earliest clinical features of variant CJD
Psychiatric and behavioural features
Inheritance pattern of familial CJD
Autosomal dominant
Histological appearance of the grey matter in CJD
Spongiform changes
Round vacuoles in the neuropil
Vacuoles joining to form microcysts
Chromosome where the gene which codes for prion protein is found
20
Abnormal form of prion protein found in CJD
PrPSc
Other parts of the body where PrPSc may be found in CJD
Skeletal muscle
Spleen
Staining used to identify PrPSc in CJD
Immunoperixodase staining
MRI sign seen with variant CJD
Pulvinar sign
EEG changes classically seen with sporadic CJD
Triphasic sharp waves 1-2 per second
Abnormal protein sometimes found in the CSF with CJD
14-3-3
Most common type of CJD where protein 14-3-3 is found
Sporadic
Percentage of classic CJD which is familial
10-15%
Type of lymphocytes which are reduced in HIV infection
CD4+
Cells which are activated by HIV infection and which kill HIV-infected cells
CD8+ cells
Most common psychiatric presentation in patients with AIDS
HIV-related dementia
Second most common psychiatric presentation in patients with AIDS
Depression
Most common cerebral lesion in patients with HIV
Toxoplasmosis
Ventricles enlarged in schizophrenia
Lateral
Part of the lateral ventricle enlarged in schizophrenia
Temporal horn
CT appearance of toxoplasmosis
Ring enhancing lesions +/- mass effect
CT appearance of primary CNS lymphoma associated with HIV
Single (or sometimes multiple) homogenous enhancing lesion
Area of the brain which sees reduced asymmetry in schizophrenia
Planum temporale
Impact of schizophrenia on brain volume
Reduced by up to 5%
Areas of the brain which see reduced cell numbers in schizophrenia
Hippocampus
Dorsolateral prefrontal cortex
Superior temporal gyrus
Most common functional imaging appearances in schizophrenia
Reduced activation of frontal regions during cognitive tasks
Functional imaging appearances seen during hallucinations in schizophrenia
Increased activation of temporal regions
Common imaging finding in mood disorders seen on T2 weighted images, especially in older people
White matter hyperintensities particularly in the deep subcortical white matter
Areas of the brain where hypoplasia is seen in autism
Cerebellar vermis
Cerebellar hemispheres
Areas of the brain which see degenerative changes in Wernicke’s encephalopathy
Mamillary bodies Hypothalamus Mediodorsal thalamus Colliculi Midbrain tegmentum
Area of the brain which shows depigmentation in Parkinson’s disease
Substantia nigra
Abnormal protein seen in Alzheimer’s disease which correlates best to clinical severity
Neurofibrillary tangles
CSF finding which can indicate worse prognosis in those with mild cognitive impairment
Increased tau to amyloid ratio
Age of patients with mood disorders where white matter hyperintensities are more often seen
Elderly patients
Physical disease which white matter hyperintensities can be associated with
Vascular disease
Type of dysarthria characterised by explosive and forceful, but slow speech
Spastic dysrathria
Type of dysarthria characterised by a breathy, nasal voice
Flaccid dysarthria
Type of dysarthria characterised by slow, quiet, tremulous speech
Hypokinetic dysarthria
Type of dysarthria characterised by a variable rate and inappropriate stoppages, and a strained quality
Hyperkinetic dysarthria
Type of dysarthria characterised by rapid, monotone, slurred speech
Ataxic dysarthria
Type of dysarthria associated with pseudobulbar palsy
Spastic dysarthria
Type of dysarthria associated with spastic hemiplegia
Spastic dysarthria
Type of dysarthria associated with myasthenia gravis
Flaccid dysarthria
Type of dysarthria associated with Parkinson’s disease
Hypokinetic dysarthria
Type of dysarthria associated with Huntington’s disease
Hyperkinetic dysarthria
Type of dysarthria associated with Syndenham’s chorea
Hyperkinetic dysarthria
Type of dysarthria associated with tardive dyskinesia
Hyperkinetic dysarthria